Intermittent Fasting (IF) Has Gained Recognition as a Promising Weight Loss Approach That Improves Body Weight, Insulin Resistance, and Metabolism. While Standard Diets Are Common in PCOS Management, IF May Address the Underlying Causes of Weight Gain and Offer Additional Metabolic Benefits

Effects of Different Dietary Programs on Anthropometric Parameters in Women With Polycystic Ovary Syndrome

The goal of this clinical trial is to learn if dietary interventions works to improve anthropometric measures in women with PCOS. The main questions it aims to answer are:

• Does intermittent fasting (IF) cause loss of body weight, fat and muscle mass?
• Can IF be considered more effective to medical and standart nutrition therapy (SDT)?
• What dietary problems do participants have when having IF diet?

Participants will:

• Follow IF, SDT, or no intervention for 8 weeks.
• Visit the clinic once every 2 weeks for check ups with a total of 5 visits for intervention groups IF and STD, visit at the beginning, second week and at the end for control group
• Keep dietary records

It was conducted in individuals who were diagnosed with PCOS as a result of clinical, biochemical and ultrasonographic medical evaluation by a gynecologist.

Inclusion Criteria:

• Voluntariness to participate in the study
• BMI between 25-35 kg/m2
• Women between the ages of 18-45

Exclusion Criteria:

• An endocrine disorder other than polycystic ovary syndrome
• Chronic liver and kidney disease,
• Diabetes,
• Hypertension,
• Hyperuricemia,
• Heart Failure,
• Thyroid disease,
• Pregnant and breastfeeding women,
• Individuals with psychiatric disorders,
• Oncological diseases,
• Women using medication,
• Those with pacemakers and platinum,
• Those with special nutritional needs